Evaluation of diabetes mellitus type 2 effects on kidney function

Abstract :

Type 2 Diabetes mellitus contributes to the development or progression of many chronic and age-related pathological processes. One of the major risk factors for morbidity and mortality among patients with diabetes is renal and vascular disease as well as heart disease. Type 2 diabetes mellitus was associated with a significantly increased age of kidney disease with higher urea and creatinine levels. 76 Libyan subjects participated in the study. The subjects were divided into three categories. One group hosts diabetes case (n=40) while the other group serves as a control (n=12) and the other group has no type 2 diabetes mellitus but urea and creatinine levels are elevated (n=36). After oral informed consent of the study participants, 5 ml of venous blood was drawn under sterile conditions for whole blood analysis. Fasting blood sugar was analyzed. Urea and creatinine levels were compared between diabetic and non-diabetic patients. However, a statistical analysis was performed using IBM SPSS version 26 where the correlation between parameters was analyzed by an independent samples t-test. In this study, patients with type 2 diabetes mellitus caused a significant increase in urea and creatinine compared to the control group. The study indicated that type 2 diabetes mellitus increases the damage to the kidney function.

1. Galtier F (2010) Definition, epidemiology, risk factors. Diabetes and Metabolism. 36 (6, 2): 628-651. doi: 10.1016/ j.diabet.2010.11.014.
2. Carrillo-Larco RM, Barengo NC, Albitres-Flores L, Bernabe-Ortiz A (2019) The risk of mortality among people with type 2 diabetes in Latin America: a systematic review and meta-analysis of population-based cohort studies. Diabetes/Metabolism Research and Reviews. 35 (4): e3139. doi: 10.1002/dmrr.3139
3. Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, de Boer IH (2016) Clinical manifestations of kidney disease among US adults with diabetes. 1988-2014. JAMA. 316 (6): 602-610. doi: 10.1001/jama.2016. 10924
4. Bailey RA, Wang Y, Zhu V, Rupnow MF (2014) Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Research Notes. 7: 415. doi: 10.1186/1756-0500-7-415
5. Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KA, Zoungas S, Rossing P, Groop P-H, Cooper ME (2015) Diabetic kidney disease. Nature Reviews, Disease Primers. 1: 15018. doi: 10.1038/nrdp.2015.18
6. Bjerg L, Hulman A, Carstensen B, Charles M, Jorgensen ME, Witte DR (2018) Development of microvascular complications and effect of concurrent risk factors in type 1 diabetes: a multistate model from an observational clinical cohort study. Diabetes Care. 41 (11): 2297-2305. doi: 10.2337/dc18-0679
7. Valencia WM, Florez H (2017) How to prevent the microvascular complications of type 2 diabetes beyond glucose control. The British Medical Journal. 356: i6505. doi: 10.1136/bmj.i6505
8. Cameron JS (2006) The discovery of diabetic nephropathy: from small print to centre stage. Journal of Nephrology. 19 (Suppl 10): S75-S87. PMID: 16874718.
9. Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clinical Journal of the American Society of Nephrology. 12 (12): 2032-2045. doi: 10.2215/CJN.11491116
10. Ritz E, Rychlík I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. American Journal of Kidney Disease. 34 (5): 795-808. doi: 10.1016/S0272-6386(99)70035-1
11. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L (2014) Changes in diabetes- related complications in the United States, 1990-2010. The New England Journal of Medicine. 370 (16): 1514-1523. doi: 10.1056/NEJMoa1310799
12. Hussain S, Chowdhury TA (2019) The impact of comorbidities on the pharmacological management of type 2 diabetes mellitus. Drugs. 79 (3): 231-242. doi: 10.1007/s40265-019-1061-4
13. Kempegowda P, Chandan JS, Abdulrahman S, Chauhan A, Saeed MA (2019) Managing hypertension in people of African origin with diabetes: Evaluation of adherence to NICE Guidelines. Primary Care Diabetes. 13 (3): 266-271. doi: 10.1016/j.pcd.2018.12.007
14. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK (2016) Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 11: 95-104. doi: 10.4137/BMI.S38440
15. Corbett JV, Banks A (2018) Laboratory tests and diagnostic procedures with nursing diagnoses. Pearson, 9th ed. ISBN: 978-0134749389.
16. Pagana KD, Pagana TJ (2015) Mosby's manual of diagnostic and laboratory test reference. 12th ed. St. Louis, Elsevier Mosby Inc. ISBN: 978-0-323-22576-2.
17. Qi C, Mao X, Zhang Z, Wu H (2017) Classification and differential diagnosis of diabetic nephropathy. Journal of Diabetes Research. 2017: 8637138. doi: 10.1155/2017/8637138
18. Rodriguez-Poncelas A, Garre-Olmo J, Franch-Nadal J, Diez-Espino J, Mundet-Tuduri X, Barrot-De la Puente J, Coll-de Tuero G, Red GDPS Study Group (2013) Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. BMC Nephrologly. 14, 46. 14: 46. doi: 10.1186/1471-2369-14-46
19. Dwyer JP, Parving HH, Hunsicker LG, Ravid M, Remuzzi G, Lewis JB (2012) Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND study. Cardiorenal Medicine. 2 (1): 1-10. doi: 10.1159/000333249
20. Aldler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS GROUP (2003) Development and progression of nephropathy in type 2 diabetes (the United Kingdom prospective diabetes study). Kidney International. 63 (1): 225-32. doi: 10.1046/j.1523-1755.2003.00712.x
21. Tufan F, Yıldız A, Dogan I, Yıldız D, Sevinir S (2015) Urea to creatinine ratio: a forgotten marker of poor nutritional state in patients undergoing hemodialysis treatment. Aging Male. 18 (1): 49-53. doi: 10.3109/13685538.2014. 908281
22. Ashavaid TF, Todur SP, Dherai AJ (2005) Establishment of reference intervals in Indians population. Indian Journal of Clinical Biochemistry. 20: 110-118. doi: 10.3109/13685538.2014.908281
23. Elmiladi SA, Elgdhafi EO (2023) Prevalence of cardiovascular risk factors in Libyan patients with type 2 diabetes mellitus. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 3 (2): 27-35. doi: 10.5281/zenodo. 7877416
24. Elmiladi SA, Elmurabth S (2021) Therapy and characteristics of hypoglycemia in admitted diabetic patients. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 1 (4): 77-83. doi: 10.528/zenodo.5806156

Citation :

Rajab et al. (2023) Evaluation of diabetes mellitus type 2 effects on kidney function in Libya. Mediterr J Pharm Pharm Sci. 3 (4): 90-96. https://doi.org/10.5281/zenodo.10396239